|
MYH9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.206800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.376440E-01 |
| Normal-vs-Stage2 |
3.355800E-01 |
| Normal-vs-Stage3 |
8.634200E-01 |
| Normal-vs-Stage4 |
5.577200E-01 |
| Stage1-vs-Stage2 |
3.956200E-02 |
| Stage1-vs-Stage3 |
9.438100E-02 |
| Stage1-vs-Stage4 |
5.621900E-02 |
| Stage2-vs-Stage3 |
4.187600E-01 |
| Stage2-vs-Stage4 |
6.949000E-01 |
| Stage3-vs-Stage4 |
6.611200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.532200E-01 |
| Normal-vs-AfricanAmerican |
9.941200E-01 |
| Normal-vs-Asian |
7.373400E-01 |
| Caucasian-vs-AfricanAmerican |
7.238800E-01 |
| Caucasian-vs-Asian |
7.575600E-01 |
| AfricanAmerican-vs-Asian |
7.230400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.545800E-01 |
| Normal-vs-Female |
3.731000E-01 |
| Male-vs-Female |
3.440400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.137790E-01 |
| Normal-vs-Age(41-60Yrs) |
1.001640E-01 |
| Normal-vs-Age(61-80Yrs) |
5.381400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.583800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.855800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.112100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.795940E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.380600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.014150E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.096850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.979000E-04 |
| Normal-vs-Grade 2 |
3.018400E-01 |
| Normal-vs-Grade 3 |
7.499800E-01 |
| Normal-vs-Grade 4 |
7.971200E-01 |
| Grade 1-vs-Grade 2 |
9.537200E-03 |
| Grade 1-vs-Grade 3 |
1.037130E-03 |
| Grade 1-vs-Grade 4 |
2.741000E-03 |
| Grade 2-vs-Grade 3 |
1.112560E-01 |
| Grade 2-vs-Grade 4 |
2.524000E-01 |
| Grade 3-vs-Grade 4 |
9.925000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.913400E-01 |
| Normal-vs-ccB subtype |
3.367800E-01 |
| ccA subtype-vs-ccB subtype |
7.295600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.833000E-01 |
| Normal-vs-N1 |
8.139400E-01 |
| N0-vs-N1 |
8.493400E-01 |
|
|
